AbstractThe role of hyaluronan in cardiac growth has become evident, previously shown by increased myocardial levels of hyaluronan in a rat model of cardiac hypertrophy.To further investigate the role of hyaluronan and regulation of its synthesis in cardiac hypertrophy, quantitative measurements of myocardial hyaluronan concentration was correlated to gene transcription in hypertrophic cardiac tissue. Factor analysis was used to study this correlation over time. A subset of differentially expressed genes was identified with a transcriptional regulation correlating to the increased synthesis of hyaluronan, suggesting a common regulatory pathway.Four transcription factors, Myc, Fos, Junb and Egr1, were also up-regulated. Furthermore, the Ace ...
Background: Development of molecules chemically modifying the expression of crucial orchestrator(s) ...
AbstractOBJECTIVESThe goal of this study was to identify genes upregulated in the heart in human pat...
Heart failure (HF) is the common end stage syndrome of many cardiac disorders, including valve insuf...
Background. Myocardial hypertrophy is a risk factor for cardiovascular morbidity and mortality. Inde...
Background: Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essent...
Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essential for both...
During the development of hypertrophic cardiomyopathy, the heart returns to fetal energy metabolism ...
htmlabstractDuring embryonic development, cardiac valves arise at specific regions in the cardiac en...
AbstractHyaluronan matrix plays an important role during vertebrate cardiogenesis. Transcripts for t...
Hyaluronan (HA) is abundantly expressed in several human tissues and a variety of roles for HA has b...
During embryonic development, cardiac valves arise at specific regions in the cardiac endothelium th...
AbstractProteins of the LIM family are critical regulators of development and differentiation in var...
AbstractCardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unra...
BACKGROUND:Development of molecules chemically modifying the expression of crucial orchestrator(s) o...
AbstractIn the mammalian heart, the development of cardiac hypertrophy is a common feature that norm...
Background: Development of molecules chemically modifying the expression of crucial orchestrator(s) ...
AbstractOBJECTIVESThe goal of this study was to identify genes upregulated in the heart in human pat...
Heart failure (HF) is the common end stage syndrome of many cardiac disorders, including valve insuf...
Background. Myocardial hypertrophy is a risk factor for cardiovascular morbidity and mortality. Inde...
Background: Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essent...
Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essential for both...
During the development of hypertrophic cardiomyopathy, the heart returns to fetal energy metabolism ...
htmlabstractDuring embryonic development, cardiac valves arise at specific regions in the cardiac en...
AbstractHyaluronan matrix plays an important role during vertebrate cardiogenesis. Transcripts for t...
Hyaluronan (HA) is abundantly expressed in several human tissues and a variety of roles for HA has b...
During embryonic development, cardiac valves arise at specific regions in the cardiac endothelium th...
AbstractProteins of the LIM family are critical regulators of development and differentiation in var...
AbstractCardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unra...
BACKGROUND:Development of molecules chemically modifying the expression of crucial orchestrator(s) o...
AbstractIn the mammalian heart, the development of cardiac hypertrophy is a common feature that norm...
Background: Development of molecules chemically modifying the expression of crucial orchestrator(s) ...
AbstractOBJECTIVESThe goal of this study was to identify genes upregulated in the heart in human pat...
Heart failure (HF) is the common end stage syndrome of many cardiac disorders, including valve insuf...